– Bloomberg
Ladenburg Thalmann Initiates Coverage On eMagin with Buy Rating, Announces Price Target of $3
Ladenburg Thalmann analyst Glenn Mattson initiates coverage on eMagin (AMEX:EMAN) with a Buy rating and announces Price Target of $3.
Related Posts
Cognition Therapeutics Is Recruiting For Lewy Body Dementia Phase 2 SHIMMER Trial In Seventeen Research Sites Across The U.S.
Lewy Body Dementia (LBD) patients are actively being recruited by Cognition Therapeutics, Inc. (NASDAQ:CGTX) and its clinical partners for the SHIMMER Phase 2 trial of their CT1812 oral drug therapy at 17
If You Invested $100 In This Stock 20 Years Ago, You Would Have $800 Today
Pioneer Natural Resources (NYSE:PXD) has outperformed the market over the past 20 years by 3.25% on an annualized…
Why Fresh Vine Wine Shares Are Exploding Higher
Fresh Vine Wine Inc (NASDAQ: VINE) shares are trading higher by 16.1% to $0.51 Thursday morning after the company announced an exploration of strategic opportunities to